EGFR T790M: revealing the secrets of a gatekeeper

Non-small-cell lung cancers that harbor activating mutations in the EGFR gene represent an important molecularly defined subset of lung cancer. Despite dramatic initial responses with first- and second-generation EGFR-directed tyrosine-kinase inhibitors (TKIs) against these cancers, the development...

Descripción completa

Detalles Bibliográficos
Autores principales: Ko, Brian, Paucar, Daniel, Halmos, Balazs
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5640399/
https://www.ncbi.nlm.nih.gov/pubmed/29070957
http://dx.doi.org/10.2147/LCTT.S117944

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5640399/
https://www.ncbi.nlm.nih.gov/pubmed/29070957
http://dx.doi.org/10.2147/LCTT.S117944

Ejemplares similares